TURTLE CAMERON (Chief Executive Officer) sold 2.6% of their position (15K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.31M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/4/2026ACC: 0001636282-26-000107
DirectorOfficer· Chief Executive Officer
Since Mar 2026
-15K
Net shares
Net seller
$1.31M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
15K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−2.50K
Price / share
$86.36
Trade value
$215.90K
% of position
0.4%
9/1/2026
567.54K→565.04K
Common Stock
Direct
Shares
−8.40K
Price / share
$87.15
Trade value
$732.06K
% of position
1.5%
9/1/2026
565.04K→556.64K
Common Stock
Direct
Shares
−3.70K
Price / share
$88.06
Trade value
$325.82K
% of position
0.7%
9/1/2026
556.64K→552.94K
Common Stock
Direct
Shares
−400.00
Price / share
$89.07
Trade value
$35.63K
% of position
0.1%
9/1/2026
552.94K→552.54K
Total
Net shares
−15K
Net value
-$1.31M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | S · Sale | −2.50K | $86.36 | $215.90K | 0.4% | 567.54K | 565.04K |
| Common Stock Direct | 9/1/2026 | S · Sale | −8.40K | $87.15 | $732.06K | 1.5% | 565.04K | 556.64K |
| Common Stock Direct | 9/1/2026 | S · Sale | −3.70K | $88.06 | $325.82K | 0.7% | 556.64K | 552.94K |
| Common Stock Direct | 9/1/2026 | S · Sale | −400.00 | $89.07 | $35.63K | 0.1% | 552.94K | 552.54K |
| Total | −15K | -$1.31M | ||||||
Derivative Transactions0
No derivative transactions reported